ASM Journals
Journal
The mission of the ASM Journals program is to advance the microbiological sciences by disseminating the results of fundamental and applied research. ASM journals publish high-quality research that has been rigorously peer reviewed by experts. Our academic editors are working scientists drawn from eminent institutions around the world. Known for the quality, rigor, and fairness of the review process, ASM Journals continue to provide current, influential coverage of basic and clinical microbial research.
ASM Journals publish 26% of all microbiology articles and contribute 44% of all microbiology citations*.
Articles published in the ASM journals receive international media attention and have been featured in the New York Times, Science Magazine, Los Angeles Times, CNN, National Public Radio (NPR), CNBC, and dozens of other media outlets.
ASM journals are written and reviewed by world-renowned authors and editors. The journals provide your faculty, staff, students, and researchers access to the most comprehensive, authoritative microbial sciences resources. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Accepts contributed content | Yes |
Recent Articles
Search ArticlesSulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease
INTRODUCTION Mycobacterium abscessus (MAB) lung disease treated with guideline-based therapy achieves sputum culture conversion in only 23%–34% of patients (1). The β-lactam antibiotics, cefoxitin and imipenem, are the backbone of guideline-based therapy (2). The poor success of guideline-based therapy is because the MAB cell wall is relatively impermeable to antibiotics, and antimicrobial resistance emergence is almost universal (3, 4).
Ceftazidime-avibactam resistance evolution in Pseudomonas aeruginosa and implications for cross-resistance to other novel β-lactams
INTRODUCTION Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen that frequently causes healthcare-associated infections (1). Isolates are often non-susceptible to preferred antipseudomonal β-lactams, and the organism’s intrinsic resistance mechanisms and ability to acquire resistance under antibacterial pressure make treatment-emergent resistance a persistent clinical challenge (1–3). Such adaptive trajectories can restrict subsequent therapy options for refractory P.
Case Commentary: When one target is not enough—PBP3 insertions and target redundancy in Escherichia coli
Antimicrobial Chemotherapy Commentary COMMENTARY Penicillin-binding proteins (PBPs) build and maintain the bacterial cell wall, and β-lactams exert antibacterial activity by inhibiting PBPs, disrupting cell wall architecture and causing bacterial death (1).
Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum
Editor's Pick Antimicrobial Chemotherapy Research Article INTRODUCTION Mycobacterium abscessus (MAB) is a highly drug-resistant nontuberculous mycobacteria (NTM) responsible for difficult-to-treat pulmonary and extrapulmonary infections (1, 2). The 2020 multi-society guidelines for the treatment of NTM pulmonary disease recommend treatment with a combination of two to six drugs, with the caveat that “the optimal drugs, regimens, and duration of therapy are not known” (1, 3).
2025 Acknowledgment of AAC Reviewers
EDITORIAL Antimicrobial Agents and Chemotherapy ’s (AAC) high-quality and timely publication of groundbreaking scientific research are critically dependent on the outstanding efforts of the Editorial Board Members ( https://journals.asm.org/journal/aac/board-editors ) who generously contribute their time, wisdom, and talents to our journal.
2025 AAC Extraordinary Service Award
EDITORIAL Antimicrobial Agents and Chemotherapy’s high quality and timely publication of groundbreaking scientific research are critically dependent on the outstanding efforts of Editorial Board Members (https://journals.asm.org/journal/aac/board-editors) and ad hoc reviewers who generously contribute their time, wisdom, and talents to our journal.
The entire CYP51B locus in azole-resistant isolates of the dermatophyte Trichophyton indotineae revealed by optical genome mapping
INTRODUCTION Trichophyton indotineae is an emerging dermatophyte that causes severe tinea corporis and tinea cruris (dermatophytosis), many of which are resistant to terbinafine and/or azole compounds (1–3).
Analysis of interactions between posaconazole/voriconazole and venetoclax
INTRODUCTION Myeloid neoplasms (MNs) are a group of clonal disorders originating from hematopoietic stem or progenitor cells. This category encompasses several malignancies, including myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), myeloproliferative neoplasm (MPN), and overlap syndromes, such as MDS/MPN (1). With the widespread use of targeted therapy and immunotherapy, the prognosis and survival rates of patients with hematological malignancies have significantly improved.
Nitroxoline exerts potent anti- Aspergillus fumigatus activity by disrupting copper homeostasis and inducing oxidative stress
INTRODUCTION Invasive pulmonary aspergillosis (IPA), primarily caused by the mold A. fumigatus, is a lethal opportunistic fungal infection afflicting immunocompromised patients, including those with hematologic malignancies, organ transplant recipients, and critically ill individuals (1).
In vitro selection and characterization of resistance to pristinamycin in Mycoplasma genitalium
INTRODUCTION Mycoplasma genitalium is a recognized sexually transmitted organism associated with 15%–25% cases of non-gonococcal urethritis in men (1). In women, it is linked to cervicitis and pelvic inflammatory disease. Only a few antimicrobial classes are active against M. genitalium, including macrolides, fluoroquinolones, tetracyclines, and streptogramin combinations (2).